New horizons in ablation therapy for hepatocellular carcinoma

References

• Ferlay J , SoerjomataramI, ErvikMet al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France (2013). http://globocan.iarc.fr
   Google Scholar
• Sartorius K , SartoriusB, AldousC, GovenderPS, MadibaTE. Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications. Cancer Epidemiol.39(3), 284–290 (2015).
   PubMed Web of Science ®Google Scholar
• Jemal A , BrayF, CenterMM, FerlayJ, WardE, FormanD. Global cancer statistics. CA Cancer J. Clin.61, 69–90 (2011).
   PubMed Web of Science ®Google Scholar
• Sherman M . Epidemiology of hepatocellular carcinoma. Oncology78, 7–10 (2010).
   PubMed Web of Science ®Google Scholar
• Llovet JM , BrúC, BruixJ. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis.19, 329–338 (1999).
   PubMed Web of Science ®Google Scholar
• Torzilli G , BelghitiJ, KokudoNet al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: An observational study of the HCC East-West study group. Ann. Surg.257(5), 929–937 (2013).
   PubMed Web of Science ®Google Scholar
• Hasegawa K , KokudoN, ImamuraHet al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann. Surg.242(2), 252–259 (2005).
   PubMed Web of Science ®Google Scholar
• Marubashi S , GotohK, AkitaHet al. Anatomical versus non-anatomical resection for hepatocellular carcinoma. Br. J. Surg.102(7), 776–784 (2015).
   PubMed Web of Science ®Google Scholar
• Sala M , LlovetJM, VilanaRet al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology40, 1352–1360 (2004).
   PubMed Web of Science ®Google Scholar
• Pompili M , De MatthaeisN, SavianoAet al. Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective? Anticancer Res. 35(1), 325–332 (2015).
   PubMed Web of Science ®Google Scholar
• Weis S , FrankeA, BergT, MössnerJ, FleigWE, SchoppmeyerK. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database Syst. Rev.1, CD006745 (2015).
   PubMedGoogle Scholar
• Yang Y , WangC, LuYet al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. W. J. Hepatobiliary Pancreat Sci.19(6), 674–684 (2012).
   PubMed Web of Science ®Google Scholar
• Huang YZ , ZhouSC, ZhouH, TongM. Radiofrequency ablation versus cryosurgery ablation for hepatocellular carcinoma: a meta-analysis. Hepatogastroenterology60(125), 1131–1135 (2013).
   PubMedGoogle Scholar
• Hong K , GeorgiadesC. Radiofrequency ablation: mechanism of action and devices. J. Vasc. Interv. Radiol.21(Suppl. 8), S179–S186 (2010).
   PubMed Web of Science ®Google Scholar
• Weis S , FrankeA, MossnerJet al. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst. Rev.12, CD003046 (2013).
   Google Scholar
• Vogl TJ , FarshidP, NaguibNNet al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom. Imaging doi:10.1007/s00261-015-0355-6 (2015) ( Epub ahead of print).
   PubMedGoogle Scholar
• Lahat E , EshkenazyR, ZendelAet al. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg. Nutr.3(5), 317–323 (2015).
   Google Scholar
• Ng KK , PoonRT, ChanSCet al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann. Surg.253(5), 981–987 (2011).
   PubMed Web of Science ®Google Scholar
• Di Costanzo GG , FrancicaG, PacellaCM. Laser ablation for small hepatocellular carcinoma: state of the art and future perspectives. World. J. Hepatol.6(10), 704–715 (2014).
   PubMedGoogle Scholar
• Lu DS , KeeST, LeeEW. Irreversible electroporation: ready for prime time?Tech. Vasc. Interv. Radiol.16(4), 277–286 (2013).
   PubMedGoogle Scholar
• Cheung W , KavnoudiasH, RobertsSet al. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Technol. Cancer Res. Treat.12(3), 233–241 (2013).
   PubMed Web of Science ®Google Scholar
• Sharma H . Role of external beam radiation therapy in management of hepatocellular carcinoma. J. Clin. Exp. Hepatol.4(Suppl. 3), S122–S125 (2014).
   PubMedGoogle Scholar
• Martin RC , MbahNA, HillRSet al. Laparoscopic versus open hepatic resection for hepatocellular carcinoma: improvement in outcomes and similar cost. World J. Surg.39(6), 1519–1526 (2015).
   PubMed Web of Science ®Google Scholar
• Livraghi T , MeloniF, SolbiatiLet al. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol.35(4), 868–874 (2013).
   Web of Science ®Google Scholar
• Kim YJ , LeeMW, ParkHS. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation. Abdom. Imaging38(1), 98–111 (2013).
   PubMedGoogle Scholar
• Arnolli MM , HanumaraNC, FrankenM, BrouwerDM, BroedersIA. An overview of systems for CT- and MRI-guided percutaneous needle placement in the thorax and abdomen. Int. J. Med. Robot. doi:10.1002/rcs.1630 (2014) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• de la Serna S , VilanaR, Sánchez-CabúsSet al. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB (Oxford)17(5), 387–393 (2015).
   PubMed Web of Science ®Google Scholar
• Sindram D , SimoKA, SwanRZet al. Laparoscopic microwave ablation of human liver tumours using a novel three-dimensional magnetic guidance system. HPB (Oxford)17(1), 87–93 (2015).
   PubMed Web of Science ®Google Scholar
• Chinnaratha MA , SathananthanD, PateriaPet al. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice. Eur. J. Gastroenterol. Hepatol.27(3), 349–354 (2015).
   PubMed Web of Science ®Google Scholar
• Kuvshinoff BW , OtaDM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery132(4), 605–611 (2002).
   PubMed Web of Science ®Google Scholar
• Winokur RS , DuJY, PuaBBet al. Characterization of in vivo ablation zones following percutaneous microwave ablation of the liver with two commercially available devices: are manufacturer published reference values useful? J. Vasc. Interv. Radiol. 25(12), 1939–1946 (2014).
   PubMed Web of Science ®Google Scholar
• Liu D , BraceCL. CT imaging during microwave ablation: analysis of spatial and temporal tissue contraction. Med. Phys.41(11), 113303 (2014).
   PubMed Web of Science ®Google Scholar
• Sugimoto K , OshiroH, OgawaSet al. Radiologic-pathologic correlation of three-dimensional shear-wave elastographic findings in assessing the liver ablation volume after radiofrequency ablation. World J. Gastroenterol.20(33), 11850–11855 (2014).
   PubMed Web of Science ®Google Scholar
• Murakami T , TakamuraM, KimTet al. Double phase CT during hepatic arteriography for diagnosis of hepatocellular carcinoma. Eur. J. Radiol.54(2), 246–252 (2005).
   PubMed Web of Science ®Google Scholar
• Kaido T , MoritaS, TanakaSet al. Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis. Markers doi:10.1155/2015/425926 (2015) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Vitale A , HuoTL, CucchettiAet al. Survival benefit of liver transplantation versus resection for hepatocellular carcinoma: impact of MELD score. Ann. Surg. Oncol.22(6), 1901–1907 (2015).
   PubMed Web of Science ®Google Scholar
• Feng Q , ChiY, LiuY, ZhangL, LiuQ. Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellularcarcinoma: a meta-analysis of 23 studies. J. Cancer Res. Clin. Oncol.141(1), 1–9 (2015).
   PubMed Web of Science ®Google Scholar
• Seledtsov VI , GoncharovAG, SeledtsovaGV. Clinically feasible approaches to potentiating cancer cell-based immunotherapies. Hum. Vaccin Immunother.11(4), 851–869 (2015).
   PubMed Web of Science ®Google Scholar
• Park EK , KimHJ, KimCYet al. A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. Ann. Surg. Treat. Res.87(2), 72–80 (2014).
   PubMed Web of Science ®Google Scholar
• Annual report of Swedish Liver Registry ‘SWELIV’ (2013). www.cancercentrum.se/globalassets/cancerdiagnoser/lever-och-galla/kvalitetsregister/arsrapport-kvalitetsregister-lever-och-gallvagscancer-2013.pdf
   Google Scholar